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Association of pure red cell aplasia with T large
granular lymphocyte leukaemia
Y L Kwong, K F Wong
Abstract
Aim—To define the relation between T
large granular lymphocyte (T-LGL) leu-
kaemia and pure red cell aplasia in
Chinese patients.
Methods—Patients with T-LGL leukaemia
were identified from a consecutive series
of Chinese patients with chronic lympho-
proliferative disorders. The diagnosis of
T-LGL leukaemia was based on typical
morphological and immunophenotypical
features, and confirmed by the detection
of clonal T cell receptor gene rearrange-
ment. The clinicopathological features,
response to treatment, and long term
follow up were also examined.
Results—Five patients were identified as
having T-LGL leukaemia from a consecu-
tive series of 33 Chinese patients with
chronic lymphoproliferative disorders.
Themedian follow up time was 45 months.
An obvious lymphocytosis was present in
only two cases, although an increase in
large granular lymphocytes in the periph-
eral blood was found in four. In one case,
the LGL count was within the normal
range. Epstein–Barr virus encoded early
nuclear RNA was negative in all the cases.
There was no evidence of rheumatoid
arthritis, and none of the patients pre-
sented with recurrent infections. On fol-
low up, pure red cell aplasia occurred at
some stage of the disease in all the
patients. This responded to treatment
with cyclosporin A in two and with
antithymocyte globulin in one. Two pa-
tients remained transfusion dependent.
Conclusions—In contrast to Western pa-
tients, Chinese patients with T-LGL leu-
kaemia do not appear to suVer from
rheumatoid arthritis and recurrent infec-
tions, but pure red cell aplasia is a major
cause of morbidity in this ethnic group.
(J Clin Pathol 1998;51:672–675)
Keywords: pure red cell aplasia; large granular
lymphocyte leukaemia
T large granular lymphocyte (T-LGL) leukae-
mia is a rare chronic lymphoproliferative disor-
der of T cells characterised by anaemia,
neutropenia, and a persistent increase in large
granular lymphocytes, which are large lym-
phocytes with a low nucleus to cytoplasm ratio
and abundant cytoplasm with azurophilic
granules.1–3 T-LGL leukaemia is an uncommon
haematological disorder in the West, account-
ing for 2–5% of all chronic lymphoid
leukaemias.4 Common clinical associations
include rheumatoid arthritis and granulocyto-
penia; autoimmune cytopenias also occur, but
less commonly, while pure red cell aplasia is a
rare association.4
On the other hand, T-LGL leukaemia is
apparently more common in the East. In one
Chinese series it accounted for 9% of all
chronic lymphoproliferative disorders.5 It is also
thought to be relatively common in the
Japanese,6 although the exact incidence remains
undefined. Oriental patients with this condition
tend to present with diVerent features from
occidental patients—for example, rheumatoid
arthritis is very rare but pure red cell aplasia
appears to be much more common.5–8
We present the clinicopathological features
of five consecutive Chinese patients with
T-LGL leukaemia and report a high frequency
of pure red cell aplasia in this population.
Methods
PATIENTS
All the patients were ethnic Chinese. The diag-
nosis of T-LGL leukaemia was based on the
presence of large granular lymphocytes in the
peripheral blood and confirmed by immu-
nophenotyping. Clonal rearrangement of the T
cell receptor ã (TCRã) gene must also be
demonstrable. The diagnosis of pure red cell
aplasia was based on anaemia, reticulocytope-
nia (< 0.1%), and selective erythroid
hypoplasia/aplasia in a normocellular marrow
with normal myeloid and megakaryocytic cell
lines.8 Vitamin B-12 and folate deficiencies
were excluded. A remission of the pure red cell
aplasia was defined as an untransfused haemo-
globin of > 10 g/dl and the return of a normal
reticulocyte count. The clinical features of cases
1 to 3 had been reported briefly elsewhere.8
IMMUNOPHENOTYPING, TCRã GENE
REARRANGEMENT, AND IN SITU HYBRIDISATION
Immunophenotyping was performed on pe-
ripheral blood or bone marrow mononuclear
cells by the biotin–streptavidin method. The
mononuclear cells in the peripheral blood or
bone marrow were concentrated by Ficoll den-
sity gradient sedimentation. Cytospin slides
were prepared from the mononuclear cell sus-
pension. Membrane staining was interpreted
together with cellular morphology, while one of
the cytospin slides was simultaneously Giemsa
stained and examined. The polymerase chain
reaction (PCR) was used to demonstrate a
clonally rearranged TCRã gene, according to
McCarthy et al.9 Two pairs of Vã primers (V1:
5'-TCT GG(G/A) GTC TAT TAC TGT
GC-3'; V2: 5'-CTC ACA CTC (C/T)CA CTT
C-3', complementary to consensus sequences
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of V-I and V-II/IV families of the TCRã gene,
respectively) and two pairs of Jã primers (J1:
5'-CAA GTG TTG TTC CAC TGC C-3'; J2:
5'-GTT ACT ATG AGC (T/C)TA GTC C-3',
complementary to consensus sequences of Jã1/ã2
and Jp1/p2 of the TCRã gene, respectively) were
used to amplify the rearranged TCRã gene.
These primer combinations would be expected
to generate bands of about the size range 75 to
95 base pairs for the V1 /V2 J1 primer pairs, and
80 to 110 base pairs for the V1/V2 J2 primer
pairs.9 In situ hybridisation for Epstein–Barr
virus encoded early RNA (EBER) was per-
formed on paraYn embedded marrow biopsies
or peripheral blood mononuclear cell cytospin
preparations as previously described.10
Results
CLINICOPATHOLOGICAL FEATURES
Four male patients and one female were
diagnosed as having T-LGL leukaemia among
33 consecutive unselected patients with
chronic lymphoproliferative diseases who pre-
sented in a six year period (1991 to 1996). The
clinicopathological features of these patients
are shown in table 1. The median age at pres-
entation was 51 years (range 47 to 73).
The initial symptoms were anaemia in four
cases and peripheral neuropathy in one.
Recurrent infection was not observed in any
patient. Neither clinical nor serological evi-
dence of rheumatoid arthritis was present in
any of the cases. At presentation, an increase in
the percentage of large granular lymphocytes
was found in four cases, the absolute LGL
count ranging from 0.68 to 11.6 × 109/l. These
cells showed considerable variation in size and
morphology (fig 1). Bone marrow examination
of these patients showed a variable infiltration
by large granular lymphocytes, ranging from to
25% to 45%. The direct antiglobulin test was
negative. Pure red cell aplasia was present in
two cases at presentation. Case 3 did not have
an increase in LGL count in the peripheral
blood and marrow at any stage of her disease,
and this accounted for the original diagnosis of
idiopathic pure red cell aplasia. T-LGL leukae-
mia was suspected three years after presenta-
tion because of the presence of LGL cells of
atypical morphology (fig 1). In the other three
cases, pure red cell aplasia developed six, 10,
and 26 months after presentation.
IMMUNOPHENOTYPING, TCRã GENE
REARRANGEMENT, AND IN SITU HYBRIDISATION
Immunophenotypic studies showed that the
large granular lymphocytes expressed the
immunophenotype CD2+CD3+CD4−CD8+
CD56− in all cases. PCR for the TCRã gene
showed clonal rearrangements in all (fig 2). In
cases 3 and 4, two bands were amplified
consistently with the biallelic TCRã gene rear-
rangements that occur in about 40% of T cell
malignancies.9 In case 3, PCR was performed
retrospectively on the marrow obtained initially
at the diagnosis of pure red cell aplasia, and
showed that a clonal population of T cells
Table 1 Clinicopathological features on presentation and treatment outcome in five Chinese patients with T large granular lymphocyte (LGL) leukaemia
Case Sex/age Hb
WBC
(%LGL)
Platelet
count
(×109/l)
Marrow
LGL
(%)
Immuno-
phenotype
of LGL
EBV
EBER
Associated
disease
(months from
diagnosis)
Response of PRCA to treatment (months or courses
given)
Follow up
(months)Steroids† HDM CsA ATG Others
1 M/47 6.5 15.0 (65) 145 37 CD2+CD3+
CD4−CD8+
CD56−
−ve PRCA (6) NR (4) NR
(1)
NR
(6)
R (1) Myleran‡
NR (6)
Transfusion
independent
(45)
2 M/48 6.0 20.0 (58) 360 45 CD2+CD3+
CD4−CD8+
CD56−
−ve PRCA (26) NR (4) NR
(1)
NR
(6)
NR
(1)
Myleran‡
NR (6),
CTX NR
(3), DCF
NR (7)
Transfusion
dependent
(55)
3 F/73 5.8 4.0 (2) 150 Not
incr
CD3+CD4−
CD8+
−ve PRCA (P) NR (6) NR
(1)
NR
(3)
NR
(1)
IVIg NR (1) Transfusion
dependent
(49)
4 M/51 4.7 2.5 (27) 161 30 CD2+CD3+
CD4−CD8+
CD56−
−ve PRCA (P) – – R (9) – – Transfusion
independent
(12)
5 M/50 13.9 4.1 (54) 225 25 CD2+CD3+
CD4−CD8+
CD56−
−ve PRCA (10),
peripheral
neuropathy
(P)
– – R (3) – – Transfusion
independent
(24)
ATG, antithymocyte globulin (Atgam, Upjohn; 25 mg/kg/d × 5); CsA, cyclosporin (8 mg/kg/d); CTX, cyclophosphamide (100 mg/d); DCF, deoxycoformycin (4
mg/kg/course); EBV EBER, Ebstein–Barr virus encoded early RNA; Hb, haemoglobin (g/dl); HDM, high dose methylprednisolone (1 g/d × 3, then 0.5 g/d × 3);
IVIg, intravenous immunoglobulin (40 mg/kg/d × 5); incr, increased; NR, non-remission, transfusion dependent; P, on presentation; PRCA, pure red cell aplasia; R,
remission (Hb > 10 g/dl, transfusion independent); WBC, white blood cell count (×109/l).
†Prednisone 1 mg/kg/d.
‡Myleran dose 4–6 mg/d.
Figure 1 Morphological variation of cells in T large granular lymphocyte (T-LGL)
leukaemia. (A) Typical LGL with voluminous pale cytoplasm containing coarse granules;
(B) LGL with pale vacuolated cytoplasm containing very fine granules; (C) LGL showing
numerous cytoplasmic villi; (D) small LGL with a central nuclear cleft, easily mistaken as
an ordinary small lymphocyte unless examined under high power. (Wright stain, ×867.)
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already existed despite the absence of an
increase in large granular lymphocytes. In situ
hybridisation for EBV EBERwas negative in all
the cases.
TREATMENT OUTCOME
In three patients who presented with pure red
cell aplasia, the initial treatment was corticos-
teroids followed by a variety of other agents
including high dose steroids, cyclophospha-
mide, cyclosporin A, intravenous immu-
noglobulin, and antithymocyte globulin (table
1). Two were refractory to treatment, but one
responded to antithymocyte globulin and
became transfusion independent. In two other
patients, the initial treatment was cyclosporin
A, starting at 8 mg/kg/day in two divided doses.
Both achieved a remission. The LGL count in
cases 1 and 2 decreased to less than 2 × 109/l
with treatment, while in cases 3–5 it remained
stable.
Discussion
This series illustrates several clinicopathologi-
cal diVerences between oriental patients with
T-LGL leukaemia and their occidental coun-
terparts. First, the overall frequency of T-LGL
leukaemia was 15% in this series from a single
tertiary referral centre, which is higher than
that reported in our previous multicentre study
of Chinese patients with chronic lymphoprolif-
erative disorders (9%).5 This might be attribut-
able to a diVerence in referral patterns.
However, both frequencies are higher than the
figure of 2–5% in Western series.4 Second,
none of our cases had clinical or serological
evidence of rheumatoid arthritis. In fact, rheu-
matoid arthritis was not observed in any of the
patients with T-LGL leukaemia reported in
two Japanese and Chinese series.5 6 Again, this
is in contrast to Western series, where there is
serological evidence of rheumatoid arthritis in
as many as 30–50% of cases.4 Third, recurrent
infections were not the presenting symptoms
and were not a major problem in any of our
cases, nor in any of the previously reported ori-
ental patients.5 6
On the other hand, pure red cell aplasia was
observed in all our patients. These findings are
in agreement with data on Japanese patients
with T-LGL leukaemia, in whom the frequency
of pure red cell aplasia is as high as 64%.6 Dur-
ing our study period, another four cases of pure
red cell aplasia were seen (one was idiopathic,
the others secondary to myeloma, B chronic
lymphocytic leukaemia, and myelodysplasia;
unpublished observations). Therefore, nearly
half of all our patients with pure red cell apla-
sia had T-LGL leukaemia. These findings indi-
cate a close association between T-LGL
leukaemia and pure red cell aplasia in oriental
patients. This association is thought to be very
uncommon in occidental ethnic groups.4 11–13
However, a recent report on cases of pure red
cell aplasia studied for TCR gene rearrange-
ment in occidental patients showed that 19%
had T-LGL leukaemia, suggesting a more
common association than was previously
recognised.14 Furthermore, as only some of the
patients had been investigated by molecular
methods in that study, the actual frequency
might be higher.15 The importance of this
observation is that in oriental patients, and
perhaps also in occidental patients, an underly-
ing T-LGL leukaemia should be excluded in
the diagnostic evaluation of pure red cell apla-
sia.
Two of our cases had only modest increases
in LGL counts,making the diagnosis ofT-LGL
leukaemia diYcult. This is illustrated in case 3
who had no increase in LGL count, although a
clonal T cell proliferation was already demon-
strable by PCR in the initial diagnostic marrow
sample. In these cases, abnormal morphology
of the large granular lymphocytes and nuclear
atypia might be a clue, but the definitive diag-
nosis depended on the demonstration of a
clonal expansion of T cells. It is therefore
important to recognise that lymphocytosis may
not be obvious in patients with T-LGL leukae-
mia, and unless the blood film is examined
carefully and periodically the diagnosis may be
overlooked, as about 8% of cases of T-LGL
leukaemia have an LGL count of less than 1 ×
109/l.4 Furthermore, molecular studies for
clonal T cell proliferation should be performed
in clinical situations where T-LGL leukaemia is
a diagnostic possibility.
No evidence of EBV infection was demon-
strable in any of our cases, consistent with the
observations from other reports.16 This sug-
gests that EBV is not involved in the pathogen-
esis of T-LGL leukaemia, even in a population
like ours where EBV is known to be associated
with many malignancies such as nasopharyn-
geal carcinoma and nasal lymphoma.17
Finally, although a remission of the pure red
cell aplasia was achieved in three cases after
treatment, the T-LGL leukaemia remained
unchanged. In two other patients, treatment of
the red cell aplasia was unsatisfactory, despite
the use of cyclophosphamide and cyclosporin–
reported to be the most eVective treatment.14
New treatments are needed to avoid the long
term complications of transfusion. We are cur-
rently evaluating the use of purine analogues
including deoxycoformycin18 in some of our
patients.
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